Merck & Co., Inc. Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Merck & Co., Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Merck & Co., Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$5.76B, a 105% decline year-over-year.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$7.03B, a 46.2% decline from 2023.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$4.81B, a 47.3% increase from 2022.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$9.12B.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Merck & Co., Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$5.76B -$2.94B -105% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q1 2024 -$2.81B -$760M -37% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q1 2023 -$2.05B +$1.03B +33.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q1 2022 -$3.09B -$988M -47.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$2.1B -$608M -40.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$1.49B +$124M +7.68% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 -$1.61B +$1.11B +40.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$2.72B -$4.18B -286% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $1.46B +$4.33B Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$2.87B -$8.02B -156% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $5.16B +$3.54B +218% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $1.62B +$3.04B Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 -$1.42B -$696M -96% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$725M +$447M +38.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 -$1.17B -$2.11B -224% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q1 2010 $942M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09

Merck & Co., Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.03B -$2.22B -46.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$4.81B +$4.31B +47.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$9.12B Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2020 -$2.83B +$6.03B +68% Jan 1, 2020 Dec 31, 2020 10-K 2021-02-25
2019 -$8.86B +$4.3B +32.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$13.2B -$3.15B -31.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$10B -$962M -10.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$9.04B -$3.66B -67.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$5.39B +$9.86B +64.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$15.2B -$9.25B -154% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$5.99B -$2.72B -83.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$3.27B +$3.64B +52.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$6.9B -$1.46B -26.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 -$5.44B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.